Topics

CAR T-Cell Products Among Top Advances in Non-Hodgkin Lymphoma

15:43 EST 31 Jan 2020 | OncLive

Praveen Ramakrishnan, MD, spotlights some of the exciting data recently presented across the spectrum of non-Hodgkin lymphoma treatment.

Original Article: CAR T-Cell Products Among Top Advances in Non-Hodgkin Lymphoma

NEXT ARTICLE

More From BioPortfolio on "CAR T-Cell Products Among Top Advances in Non-Hodgkin Lymphoma"

Quick Search

Relevant Topic

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...